clinical trial · NCT07314320
A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men
Otsuka Pharmaceutical Development & Commercialization, Inc.·phase1·completed·n = 8
Healthy Volunteers[14C]-OPC-167832
brief summary
The purpose of this study is to determine the relative amounts of radioactivity excreted in urine and feces following a single oral dose of \[14C\]-OPC-167832 in healthy male participants.
started
Nov 20, 2023
primary completion
Dec 27, 2023
completion
Dec 27, 2023
last updated
Jan 2, 2026
official title
A Phase 1, Open-Label, Single-Dose Trial to Evaluate the Mass Balance and Pharmacokinetics of [14C]-OPC-167832 Administered Orally in Healthy Male Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol